Daunorubicin hydrochloride is a chemotherapy medication used in cancer treatment. It is specifically indicated for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 23541-50-6
Daunorubicin
pharmaceutical raw material
Doxorubicin hydrochloride
pharmaceutical raw material
Epirubicin hydrochloride
pharmaceutical raw material
Doxorubicin
pharmaceutical raw material
Idarubicin hydrochloride
pharmaceutical raw material
Deiodoamiodarone
pharmaceutical raw material
Clotrimazole
pharmaceutical raw material
Quinapyramine dichloride
pharmaceutical raw material
The international HS code for DAUNORUBICIN HYDROCHLORIDE (CAS 23541-50-6) is 2941.90.
2941.90
2941 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
GUGHGUXZJWAIAS-QQYBVWGSSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl